Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Vitamin D3 Streuli" (108)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Colecalciferol (A11CC05) 52 products
WHO-DDD
DrugBank.ca
L
IP
CI
Dekristol 20.000 I.E.
4
2.95
7.50
10 %
Soft capsules: Cholecalciferolum
Dermapharm AG
B / SL
FB
G
L
IP
CI
Dekristol 20.000 I.E.
14
10.33
20.10
10 %
Soft capsules: Cholecalciferolum
Dermapharm AG
B / SL
FB
G
Trederol 5000 I.E.
20
PR
PR
k.A.
Coated tablets: Cholecalciferolum 5000 UI
Maras AG
B
FB
G
Trederol 5000 I.E.
40
PR
PR
k.A.
Coated tablets: Cholecalciferolum 5000 UI
Maras AG
B
FB
G
Trederol 20000 I.E.
5
PR
PR
k.A.
Coated tablets: Cholecalciferolum 20000 UI
Maras AG
B
FB
G
IP
CI
Dekristol 20.000 I.E.
3
PR
PR
k.A.
Soft capsules: Cholecalciferolum
Dermapharm AG
B
FB
G
IP
CI
Dekristol 20.000 I.E.
6
PR
PR
k.A.
Soft capsules: Cholecalciferolum
Dermapharm AG
B
FB
G
IP
CI
Dekristol 20.000 I.E.
14
PR
PR
k.A.
Soft capsules: Cholecalciferolum
Dermapharm AG
B
FB
G
IP
CI
Dekristol 20.000 I.E.
50
PR
PR
k.A.
Soft capsules: Cholecalciferolum
Dermapharm AG
B
FB
G
Ciferavit D3 zur
Prophylaxe
10 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Medius AG
D
FB
G
Ciferavit D3 zur Therapie
30 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Medius AG
B
FB
G
IP
CI
CM
Vi-De 3 Huile 0.5 mg/ml
10 ml
PR
PR
k.A.
ölige Lösung zum Einnehmen: Cholecalciferolum
VERFORA SA
D
FB
G
L
IP
CI
Vitamin D3 Streuli 20`000
I.E. Weichkapseln
4
4.22
8.95
10 %
Cholecalciferolum 20000 UI
Streuli Pharma AG
B / SL
FB
G
L
IP
CI
Vitamin D3 Streuli 20`000
I.E. Weichkapseln
12
12.66
26.85
10 %
Cholecalciferolum 20000 UI
Streuli Pharma AG
B / SL
FB
G
L
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
6
7.65
17.00
10 %
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B / SL
FB
G
L
IP
CI
Lundeos
4
4.28
9.00
10 %
Soft capsules: Cholecalciferolum 20000 UI
Future Health Pharma
GmbH
B / SL
FB
G
L
IP
Vitamin D3 Sandoz eco
1000 I.E.
30
1.68
3.10
10 %
Soft capsules: Cholecalciferolum 1000 UI
Sandoz
Pharmaceuticals AG
D / SL
FB
G
L
IP
Vitamin D3 Sandoz eco
1000 I.E.
90
5.04
9.30
10 %
Soft capsules: Cholecalciferolum 1000 UI
Sandoz
Pharmaceuticals AG
D / SL
FB
G
L
IP
Vitamin D3 Sandoz eco
3200 I.E.
30
5.38
14.40
10 %
Soft capsules: Cholecalciferolum 3200 UI
Sandoz
Pharmaceuticals AG
B / SL
FB
G
L
IP
Vitamin D3 Sandoz eco
3200 I.E.
90
16.13
34.95
10 %
Soft capsules: Cholecalciferolum 3200 UI
Sandoz
Pharmaceuticals AG
● 
B / SL
FB
G
L
IP
Vitamin D3 Sandoz eco
25000 I.E.
4
5.60
14.65
10 %
Soft capsules: Cholecalciferolum 25000 UI
Sandoz
Pharmaceuticals AG
B / SL
FB
G
L
IP
CI
Vitamin D3 Spirig HC
30
1.36
2.50
10 %
Soft capsules: Cholecalciferolum 800 UI
Spirig HealthCare AG
D / SL
FB
G
L
IP
CI
Vitamin D3 Spirig HC
90
4.08
7.55
10 %
Soft capsules: Cholecalciferolum 800 UI
Spirig HealthCare AG
D / SL
FB
G
IP
CI
CM
Luvit D3 zur Prophylaxe
10 ml
2.31
4.25
10 %
Solution (oral): Cholecalciferolum 4000 UI/ml
Drossapharm AG
D / SL
FB
G
IP
CI
CM
Luvit D3 zur Therapie
30 ml
6.93
16.15
10 %
Solution (oral): Cholecalciferolum 4000 UI/ml
Drossapharm AG
B / SL
FB
G
L
IP
CI
Vi-De 3 dose par mois
5 ml
1.42
2.60
10 %
Solution (oral): Cholecalciferolum 600µg / 5ml
VERFORA SA
D / SL
FB
G
L
IP
CI
Vi-De 3 dose par mois
3 x 5 ml
4.26
9.00
10 %
Solution (oral): Cholecalciferolum 600µg / 5ml
VERFORA SA
B / SL
FB
G
L
IP
CI
Vi-De 3 dose par mois
6 x 5 ml
8.52
18.00
10 %
Solution (oral): Cholecalciferolum 600µg / 5ml
VERFORA SA
B / SL
FB
G
L
IP
CI
Viferol D3 25'000 UI/ml
4
5.59
14.65
10 %
Solution (oral): Cholecalciferolum 25000 UI/ml
OM Pharma Suisse SA
B / SL
FB
G
IP
CI
Vitamin D3 Streuli
Prophylax
10 ml
2.31
4.25
10 %
Solution (oral): Cholecalciferolum 4000 UI/ml
Streuli Pharma AG
D / SL
FB
G
IP
CI
Vitamin D3 Streuli
Prophylax
30 ml
6.93
16.15
10 %
Solution (oral): Cholecalciferolum 4000 UI/ml
Streuli Pharma AG
B / SL
FB
G
IP
CI
Vi-De 3
10 ml
2.50
4.60
10 %
Drops: Cholecalciferolum 4500 UI/ml
VERFORA SA
D / SL
FB
G
IP
CI
DIBASE 10'000
Flasche(n) à 10 ml
5.00
9.25
10 %
orale Tropflösung: Cholecalciferolum 10000 UI/ml
Gebro Pharma AG
D / SL
FB
G
IP
CI
DIBASE 10'000
10 ml
5.00
9.25
10 %
orale Tropflösung: Cholecalciferolum 10000 UI/ml
Gebro Pharma AG
D / SL
FB
G
L
IP
CI
Vitamin D3 Spirig HC 2740
I.E./ml
25 ml
3.88
7.15
10 %
ölige Lösung zum Einnehmen: Cholecalciferolum 2740 UI/ml
Spirig HealthCare AG
● 
D / SL
FB
G
IP
CI
Vitamin D3 Wild huile
10 ml
PR
PR
k.A.
Cholecalciferolum
VERFORA SA
D
FB
G
IP
CI
Vitamin D3 Streuli
10 ampoule(s)
PR
PR
k.A.
Injection solution: Cholecalciferolum 300000 UI/ml
Streuli Pharma AG
B
FB
G
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
4
PR
PR
k.A.
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
8
PR
PR
k.A.
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
12
PR
PR
k.A.
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IP
CI
Lundeos
2 x 4
PR
PR
k.A.
Soft capsules: Cholecalciferolum 20000 UI
Future Health Pharma
GmbH
B
FB
G
IP
Vitamin D3 Sandoz eco
25000 I.E.
8
PR
PR
k.A.
Soft capsules: Cholecalciferolum 25000 UI
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Vitamin D3 Sandoz eco
25000 I.E.
12
PR
PR
k.A.
Soft capsules: Cholecalciferolum 25000 UI
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
DIBASE 25'000
PR
PR
k.A.
Solution (oral): Cholecalciferolum 25000U.I. / 2.5ml
Gebro Pharma AG
D
FB
G
IP
CI
DIBASE 25'000
4
PR
PR
k.A.
Solution (oral): Cholecalciferolum 25000U.I. / 2.5ml
Gebro Pharma AG
B
FB
G
IP
CM
HEMONITA D3 zur
Prophylaxe
10 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Hemony Pharmaceutical
Switzerland GmbH
D
FB
G
IP
CM
HEMONITA D3 zur
Prophylaxe
20 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Hemony Pharmaceutical
Switzerland GmbH
D
FB
G
IP
CM
HEMONITA D3 zur Therapie
30 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Hemony Pharmaceutical
Switzerland GmbH
B
FB
G
IP
CI
CM
Luvit D3 zur Prophylaxe
20 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Drossapharm AG
D
FB
G
IP
CI
Vicrin D3 100'000 UI
2 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 100000U.I. / 2ml
Novasearch AG
B
FB
G
IP
CI
Viferol D3 100'000 UI / ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 100000 UI/ml
OM Pharma Suisse SA
B
FB
G
IP
CI
Vitamin D3 Streuli
Prophylax
20 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Streuli Pharma AG
D
FB
G
(Codice) 56 products
WHO-DDD
L
IP
Azacitidin Stada 150 mg
304.64
366.50
10 %
Powder for injection suspension: Azacitidinum 150 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Sonotryl
10
PR
PR
k.A.
Coated tablets: Ibuprofenum 200 mg
VERFORA SA
D
FB
G
IP
CI
Sonotryl
20
PR
PR
k.A.
Coated tablets: Ibuprofenum 200 mg
VERFORA SA
D
FB
G
IP
Xenpozyme 4 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 4 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 20 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 20 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
L
IP
CI
A
Subutex 2 mg
28 Tablet(s)
25.23
45.40
10 %
Sublingual tablets: Buprenorphinum 2 mg
Indivior Schweiz AG
A+ / SL / SO
FB
G
IP
CI
Dilzem 90 mg retard
20 Tablet(s)
3.26
7.85
10 %
Delayed release tablets: Diltiazemi Hydrochloridum 90 mg
Pfizer AG
B / SL / SO
FB
G
IP
CI
Dilzem 90 mg retard
100 Tablet(s)
14.05
28.45
10 %
Delayed release tablets: Diltiazemi Hydrochloridum 90 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Januvia 100 mg
-
T
28 Tablet(s)
26.82
47.25
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Januvia 100 mg
-
T
98 Tablet(s)
93.85
124.25
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Januvia 25 mg
-
T
28 Tablet(s)
26.82
47.25
20 %
Coated tablets: Sitagliptinum 25 mg
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Januvia 25 mg
-
T
98 Tablet(s)
93.85
124.25
20 %
Coated tablets: Sitagliptinum 25 mg
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
IP
Fentalis 25 μg/h
5
15.79
34.55
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 50 μg/h
5
31.27
52.35
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 100 μg/h
5
58.80
84.00
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 25 μg/h
10
27.66
48.20
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 50 μg/h
10
56.76
81.65
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 100 μg/h
10
103.47
135.30
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
2 g
9.90
19.60
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
10 x 2 g
84.15
113.10
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
CI
CM
Mephadolor 500 Neo
‐
I
-
T
10 Tablet(s)
1.27
5.55
10 %
Coated tablets: Acidum Mefenamicum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Mephadolor 500 Neo
‐
I
-
T
30 Tablet(s)
3.84
8.50
10 %
Coated tablets: Acidum Mefenamicum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Mephadolor 500 Neo
‐
I
-
T
100 Tablet(s)
11.14
25.10
10 %
Coated tablets: Acidum Mefenamicum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Lasix 20 mg/2 mL
5 ampoule(s)
1.61
5.95
10 %
Injection solution: Furosemidum 20mg / 2ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Salofalk 1000 mg
50 Sachet(s)
45.04
68.15
10 %
Granulate: Mesalazinum 1 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1000 mg
150 Sachet(s)
114.86
148.40
10 %
Granulate: Mesalazinum 1 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 3 g
30 Sachet(s)
78.06
106.10
10 %
Granulate: Mesalazinum 3000 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 3 g
90
199.05
245.15
10 %
Granulate: Mesalazinum 3000 mg
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Renvela 2.4 g
60 Sachet(s)
141.67
179.20
10 %
Soluble Powder: Sevelameri Carbonas 2400 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
Rixathon 500 mg/50 ml
1051.32
1215.70
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Rixathon 100 mg/10 ml
2
421.97
501.30
10 %
Concentrate for infusion: Rituximabum 100mg / 10ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
312.40
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1118.60
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
SIP
IP
CI
Xarelto 15 mg
14 Tablet(s)
32.17
53.40
10 %
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B / SL
FB
G
SIP
IP
CI
Xarelto 15 mg
28 Tablet(s)
62.83
88.60
10 %
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B / SL
FB
G
SIP
IP
CI
Xarelto 15 mg
98 Tablet(s)
230.43
281.20
10 %
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Elvanse 70 mg
30 Capsule(s)
114.64
148.15
10 %
Capsules: Lisdexamfetamini Dimesilas 70 mg
Takeda Pharma AG
A+ / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1690.75
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Ogivri 150 mg
456.84
541.40
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / SL
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
10
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
195
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
Bilaxten 6 mg / ml
5 ml
PR
PR
k.A.
Eye drops: Bilastinum 6 mg/ml
A. Menarini GmbH
B
FB
G
IP
CI
A
Subutex 2 mg
7 Tablet(s)
7.04
16.30
k.A.
Sublingual tablets: Buprenorphinum 2 mg
Indivior Schweiz AG
A+
FB
G
IP
Argatra 100mg/ml
Durchstechflasche(n) à 2.5 ml
PR
PR
k.A.
Concentrate for infusion: Argatrobanum Monohydricum 100 mg/ml
Mitsubishi Tanabe
Pharma GmbH,
Düsseldorf,
Zweigniederlassung
Lenzburg
B
FB
G
IP
Argatra 100mg/ml
6 1 Durchstechflasche(n) à 2.5 ml
PR
PR
k.A.
Concentrate for infusion: Argatrobanum Monohydricum 100 mg/ml
Mitsubishi Tanabe
Pharma GmbH,
Düsseldorf,
Zweigniederlassung
Lenzburg
B
FB
G
IP
Rixathon 500 mg/50 ml
2
PR
PR
k.A.
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Rixathon 100 mg/10 ml
3
PR
PR
k.A.
Concentrate for infusion: Rituximabum 100mg / 10ml
Sandoz
Pharmaceuticals AG
A
FB
G
SIP
IP
CI
Xarelto 15 mg
10 1 Tablet(s)
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B
FB
G
SIP
IP
CI
Xarelto 15 mg
30 x 1
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B
FB
G
SIP
IP
CI
Xarelto 15 mg
100
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B
FB
G
IP
CI
Dafalgan Grippal
12
PR
PR
k.A.
Granulat zur Herstellung einer Lösung zum Einnehmen: 3 Active Agents
UPSA Switzerland AG
D
FB
G
IP
CI
V/S
Comirnaty
195
PR
PR
k.A.
Konzentrat zur Herstellung einer Injektionsdispersion: Tozinameranum 225 µg
Pfizer AG
B
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
IP
Ceftriaxon Labatec 500 mg
i.v.
10 x 500 mg
PR
PR
k.A.
poudre pour solution injectable: Ceftriaxonum 500 mg
Labatec Pharma SA
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home